METLIFE INC·4

Nov 7, 4:16 PM ET

Townsend Christopher G 4

4 · METLIFE INC · Filed Nov 7, 2017

Insider Transaction Report

Form 4
Period: 2017-11-03
Townsend Christopher G
President, Asia Region
Transactions
  • Exercise/Conversion

    Common Stock

    2017-11-03$27.19/sh+49,660$1,350,25549,660 total
  • Sale

    Common Stock

    2017-11-03$54.60/sh49,660$2,711,6840 total
  • Exercise/Conversion

    Common Stock

    2017-11-03$31.15/sh+33,071$1,030,16233,071 total
  • Sale

    Common Stock

    2017-11-03$54.60/sh33,071$1,805,7430 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2017-11-0349,6600 total
    Exercise: $27.19Exp: 2022-07-31Common Stock (49,660 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2017-11-0333,0710 total
    Exercise: $31.15Exp: 2023-02-25Common Stock (33,071 underlying)
Footnotes (5)
  • [F1]The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  • [F2]The shares were sold in multiple transactions at prices $54.560 to $54.630, inclusive.
  • [F3]The shares were sold in multiple transactions at prices $54.600 to $54.618, inclusive.
  • [F4]The options became exercisable in three equal installments on August 1, 2013, 2014 and 2015.
  • [F5]The options became exercisable in three equal installments on February 26, 2014, 2015 and 2016.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION